Is AS Only Important When Severe?

Aortic stenosis (AS) is a progressive disease associated with morbidity and mortality, especially in severe cases. However, recent studies have revealed that moderate stenosis can also have unfavorable consequences in the course of the disease.

¿Solo es importante la estenosis aórtica severa?

One of the challenges lies in that determining its severity is sometimes difficult due to discrepancies between valve area, gradient, and peak velocity, which can lead to confusion regarding the presence of symptoms.

In a study that included 595,120 patients, 70,778 (11.9%) were identified as having some degree of AS. Of them, 48.9% had mild stenosis (L), 8.2% mild to moderate (L/M), 20.6% moderate (M), 5.2% moderate to severe (M/S), and 17.1% severe (S) stenosis.

As AS became more severe, there was an increase in age and risk factors such as hypertension, diabetes, atrial fibrillation, coronary artery disease, heart attack, percutaneous coronary intervention, myocardial revascularization surgery, chronic obstructive pulmonary disease, cancer, ejection fraction lower than 50%, smaller aortic valve area, lower gradient, and higher presence of atrioventricular valve regurgitation.

Read also: Low Gradient, Normal Flow Aortic Stenosis: Changes in Quality of Life with TAVR.

After four years of follow-up, mortality among those who did not receive treatment was 13.5% (95% CI: 13.3%-13.7%) for those without AS, and for those with mild, mild to moderate, moderate, moderate to severe, and severe AS it was 25.0%, 29.7%, 33.5%, 45.7%, and 44.9%, respectively. In those who received treatment, the mortality rate was 0.2%, 1.0%, 4.2%, 11.4%, 36.7%, and 60.7%, respectively.

In an adjusted multivariate analysis, untreated aortic stenosis, regardless of the degree, was associated with an increase in mortality.

Conclusion

In conclusion, patients with aortic stenosis face a significant risk of mortality at all severity levels without treatment. Nevertheless, aortic valve replacement remains low in cases of severe aortic stenosis, indicating the need for further research to understand diagnostic barriers and define the appropriate timing for aortic valve replacement.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: The Mortality Burden of Untreated Aortic Stenosis. 

Reference: Philippe Généreux, et al. J Am Coll Cardiol 2023;82:2101–2109. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...